Upstream Bio, Inc. (UPB)
2.74
-0.25
(-8.36%)
USD |
NASDAQ |
Oct 23, 16:00
2.735
0.00 (0.00%)
After-Hours: 20:00
Upstream Bio Market Cap : 150.07M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 150.07M |
| October 22, 2026 | 163.77M |
| October 21, 2026 | 153.36M |
| October 20, 2026 | 154.45M |
| October 19, 2026 | 153.36M |
| October 16, 2026 | 151.17M |
| October 15, 2026 | 184.58M |
| October 14, 2026 | 187.32M |
| October 13, 2026 | 194.44M |
| October 12, 2026 | 228.40M |
| October 09, 2026 | 257.42M |
| October 08, 2026 | 249.21M |
| October 07, 2026 | 252.49M |
| October 06, 2026 | 251.40M |
| October 05, 2026 | 265.64M |
| October 02, 2026 | 276.05M |
| October 01, 2026 | 276.05M |
| September 30, 2026 | 288.64M |
| September 29, 2026 | 284.26M |
| September 28, 2026 | 290.29M |
| September 25, 2026 | 293.57M |
| September 24, 2026 | 283.17M |
| September 23, 2026 | 284.26M |
| September 22, 2026 | 300.69M |
| September 21, 2026 | 293.85M |
| Date | Value |
|---|---|
| September 18, 2026 | 292.48M |
| September 17, 2026 | 290.83M |
| September 16, 2026 | 291.93M |
| September 15, 2026 | 300.15M |
| September 14, 2026 | 318.22M |
| September 11, 2026 | 313.84M |
| September 10, 2026 | 314.93M |
| September 09, 2026 | 326.44M |
| September 08, 2026 | 339.03M |
| September 04, 2026 | 329.17M |
| September 03, 2026 | 333.01M |
| September 02, 2026 | 354.92M |
| September 01, 2026 | 358.75M |
| August 31, 2026 | 362.58M |
| August 28, 2026 | 366.42M |
| August 27, 2026 | 371.90M |
| August 26, 2026 | 390.52M |
| August 25, 2026 | 393.26M |
| August 24, 2026 | 362.04M |
| August 21, 2026 | 381.75M |
| August 20, 2026 | 375.18M |
| August 19, 2026 | 411.60M |
| August 18, 2026 | 375.18M |
| August 17, 2026 | 391.06M |
| August 14, 2026 | 387.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sutro Biopharma, Inc. | 154.66M |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
Market Cap Related Metrics
| PS Ratio | 47.08 |
| PEG Ratio | -0.0233 |
| Price to Book Value | 0.5539 |
| Price | 2.74 |
| Earnings Yield | -105.3% |
| PEGY Ratio | -0.0233 |